| Symbol | ASBPW |
|---|---|
| Name | ASPIRE BIOPHARMA HOLDINGS, INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Address | 23150 FASHION DRIVE,SUITE 232, ESTERO, 33928, Puerto Rico |
| Telephone | +1 415 - 592-7399 |
| Fax | — |
| — | |
| Website | https://www.aspirebiolabs.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | — |
| Description | Aspire Biopharma is developing next generation absorption of medicine that will have a significant impact on the opioid crisis. Our nano technology drug formulation directly targets pain and inflammation bypassing the gastrointestinal tract. Aspires technology comes from a new mechanism of action (absorption pathway) which allows for instant absorption in the mouth. Benefits of "instant absorption" are to provide nearly instant treatment impact and also allows high dose absorption. Our technology can be applied to any number of proven drugs and supplements, such as analgesics, erectile dysfunction, and traumatic brain injury drugs. Additional info from NASDAQ: |
(19% Negative) ASPIRE BIOPHARMA HOLDINGS, INC. (ASBP) Announces Business Combination
Read moreNew Form 8-K/A - Aspire Biopharma Holdings, Inc. <b>Filed:</b> 2026-04-17 <b>AccNo:</b> 0001493152-26-017145 <b>Size:</b> 1 MB <br />Item 1.01: Entry into a Material Definitive Agreement <br />Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year <br />Item 9.01: Fin…
Read more(99% Neutral) ASPIRE BIOPHARMA HOLDINGS, INC. (ASBP) Announces Business Combination
Read more(99% Neutral) ASPIRE BIOPHARMA HOLDINGS, INC. (ASBPW) Announces Business Combination
Read more(30% Negative) ASPIRE BIOPHARMA HOLDINGS, INC. (ASBP) Reports Q2 2026 Financial Results
Read more(99% Neutral) ASPIRE BIOPHARMA HOLDINGS, INC. (ASBP) Announces Business Combination
Read moreNew Form EFFECT - Aspire Biopharma Holdings, Inc. <b>Filed:</b> 2026-04-14 <b>AccNo:</b> 9999999995-26-001178 <b>Size:</b> 1 KB
Read moreNew Form S-1/A - Aspire Biopharma Holdings, Inc. <b>Filed:</b> 2026-04-10 <b>AccNo:</b> 0001493152-26-016123 <b>Size:</b> 8 MB
Read moreNew Form 10-K/A - Aspire Biopharma Holdings, Inc. <b>Filed:</b> 2026-04-08 <b>AccNo:</b> 0001493152-26-015737 <b>Size:</b> 8 MB
Read more